Fdc Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is OLOPATADINE HYDROCHLORIDE USP, with a corresponding US DMF Number 29464.
Remarkably, this DMF maintains an Active status since its submission on June 23, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 28, 2016, and payment made on September 21, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II